Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
GBP | Fiscal Year Ending | | Latest |
(in millions) | Mar-15 | Mar-16 | Mar-17 | Mar-18 | Mar-19 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 764 | 756 | 783 | 833 | 911 | 1,073 | 1,278 | 1,320 | 1,581 | 1,912 | | 1,976 |
% Growth | NA | -1.1% | 3.6% | 6.4% | 9.4% | 17.8% | 19.1% | 3.3% | 19.7% | 21.0% | | |
| | | | | | | | | | | | |
Cost of Revenue | (637) | (630) | (647) | (691) | (753) | (902) | (1,088) | (1,142) | (1,352) | (1,643) | | (1,694) |
Gross Profit | 127 | 126 | 136 | 142 | 159 | 171 | 190 | 179 | 229 | 269 | | 281 |
% Revenue | 16.6% | 16.6% | 17.4% | 17.1% | 17.4% | 15.9% | 14.9% | 13.5% | 14.5% | 14.1% | | 14.2% |
| | | | | | | | | | | | |
Research and Development | (307) | (301) | (308) | (312) | (300) | (294) | (303) | (304) | (317) | (332) | | (334) |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | 0 | 0 | 0 | 0 | (2) | (2) | (1) | (2) | (2) | (1) | | (1) |
Other Inc / (Exp) | 288 | 265 | 303 | 314 | 267 | 248 | 259 | 254 | 289 | 262 | | 252 |
Total Operating Exp | (19) | (36) | (5) | 2 | (35) | (47) | (46) | (52) | (31) | (71) | | (82) |
| | | | | | | | | | | | |
Operating Income | 108 | 90 | 131 | 144 | 123 | 124 | 144 | 127 | 199 | 198 | | 199 |
% Revenue | 14.1% | 11.9% | 16.8% | 17.3% | 13.5% | 11.6% | 11.3% | 9.6% | 12.6% | 10.4% | | 10.1% |
| | | | | | | | | | | | |
Interest Expense | (2) | 0 | 0 | 0 | (0) | (1) | (2) | (1) | (7) | (15) | | (16) |
Pre-tax Income | 105 | 90 | 132 | 145 | 123 | 123 | 143 | 126 | 192 | 183 | | 183 |
Earnings of Discontinued Ops. | (13) | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 12 | 8 | (8) | (7) | (9) | (17) | (21) | (36) | (38) | (43) | | (45) |
Net Income to Company | 105 | 106 | 123 | 138 | 114 | 107 | 122 | 90 | 154 | 140 | | 139 |
% Margin | 13.7% | 14.0% | 15.7% | 16.6% | 12.5% | 9.9% | 9.5% | 6.8% | 9.8% | 7.3% | | 7.0% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | (0) | (0) | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 105 | 106 | 123 | 138 | 114 | 106 | 122 | 90 | 154 | 140 | | 139 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 13 | (8) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 117 | 99 | 123 | 138 | 114 | 106 | 122 | 90 | 154 | 140 | | 139 |
% Margin | 15.4% | 13.0% | 15.7% | 16.6% | 12.5% | 9.9% | 9.5% | 6.8% | 9.8% | 7.3% | | 7.0% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.19 | 0.17 | 0.21 | 0.24 | 0.20 | 0.19 | 0.21 | 0.16 | 0.27 | 0.24 | | 0.24 |
Diluted EPS (Continuing Ops) | 0.19 | 0.17 | 0.21 | 0.24 | 0.20 | 0.19 | 0.21 | 0.16 | 0.27 | 0.24 | | 0.24 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 630.90 | 587.00 | 573.90 | 565.20 | 566.00 | 567.00 | 569.70 | 573.20 | 575.90 | 577.00 | | 568.80 |
WA Diluted Shares Out. | 634.60 | 590.70 | 578.70 | 567.20 | 570.00 | 572.40 | 575.80 | 579.60 | 582.30 | 585.70 | | 578.70 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 105 | 90 | 132 | 145 | 123 | 123 | 143 | 126 | 192 | 183 | | 183 |
Addback: Net Interest Expense | 2 | (0) | (0) | (0) | 0 | 1 | 2 | 1 | 7 | 15 | | 16 |
Addback: Other Non Operating Expenses, Total | 1 | 0 | (0) | 1 | 0 | 1 | (1) | (0) | (1) | (1) | | (1) |
Addback: Depreciation & Amortization | 25 | 27 | 29 | 30 | 35 | 42 | 50 | 51 | 61 | 75 | | 79 |
Addback: Restructuring Charges | (1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 1 | 0 | 2 | 8 | 3 | 5 | 19 | 9 | | 8 |
Addback: Goodwill Impairment | 0 | 32 | 0 | 0 | 0 | 14 | 25 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | (1) | (1) | 0 | (0) | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | (16) | (18) | (21) | (0) | (14) | (29) | 0 | (18) | (2) | | 0 |
Addback: Asset Writedown | 1 | (0) | 0 | 0 | 6 | (0) | 1 | 2 | 0 | 1 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 1 | 1 | 1 | (4) | (8) | (7) | (7) | (3) | (24) | 11 | | 18 |
Adjusted EBITDA | 134 | 133 | 144 | 150 | 157 | 168 | 187 | 182 | 241 | 291 | | 303 |
% Margin | 17.6% | 17.6% | 18.3% | 18.0% | 17.3% | 15.7% | 14.6% | 13.8% | 15.2% | 15.2% | | 15.4% |
| | | | | | | | | | | | |
Adjusted EBIT | 110 | 107 | 115 | 120 | 122 | 126 | 137 | 131 | 180 | 216 | | 224 |
% Margin | 14.3% | 14.1% | 14.7% | 14.4% | 13.4% | 11.7% | 10.7% | 9.9% | 11.4% | 11.3% | | 11.3% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 105 | 106 | 123 | 138 | 114 | 107 | 122 | 90 | 154 | 140 | | 139 |
Addback: Unusual Items | 1 | 17 | (16) | (25) | (1) | 1 | (7) | 4 | (18) | 19 | | 26 |
Less: Tax Benefit of Unusual Items (26%) | (0) | (4) | 4 | 7 | 0 | (0) | 2 | (1) | 5 | (5) | | (7) |
Adjusted Net Income | 105 | 118 | 111 | 119 | 113 | 107 | 117 | 93 | 141 | 154 | | 158 |
% Margin | 13.8% | 15.7% | 14.2% | 14.3% | 12.4% | 10.0% | 9.1% | 7.0% | 8.9% | 8.0% | | 8.0% |